Physician

Thomas W Bender, MD

According to 2025 Medicare claims, Thomas Bender, MD (NPI: 1649266792) practices dermatology in the Mobile, AL market, with the plurality of this provider's patient population coming from Mobile, AL. This provider's primary affiliated billing organization is FOREFRONT DERMATOLOGY, S.C. (NPI: 1366936759; TIN: 391351587) and primary practice location at 36695-4614.

Bender's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,134 traditional Medicare patients, billed 14,083 HCPCS/CPT codes, and received $546,740 in Medicare payments. The top billing code was 17110 (Destruction of skin growth, 1-14 growths). Part D data shows 3,181 prescription claims across 952 beneficiaries totaling $1,396,815 in drug costs, led by Skyrizi Pen (Risankizumab-Rzaa). Open Payments data shows 174 records totaling $22,986. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved from a lower plateau to a higher plateau, from $387,634 to $1,396,815. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$309K$618K2015 Medicare payment: $471,717 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $525,729 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $471,927 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $401,895 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $408,283 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $533,842 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $514,580 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $617,502 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $584,385 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $546,740 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20151,52314,317$471,717
20162,35817,410$525,729
20172,03914,754$471,927
20181,77519,325$401,895
20191,41113,275$408,283
20201,29314,553$533,842
20211,11812,375$514,580
20221,11513,241$617,502
20231,12812,761$584,385
20241,13414,083$546,740

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$698K$1.4M2015 Drug cost: $387,634 (USD; Tot_Drug_Cst)2016 Drug cost: $400,117 (USD; Tot_Drug_Cst)2017 Drug cost: $780,494 (USD; Tot_Drug_Cst)2018 Drug cost: $605,345 (USD; Tot_Drug_Cst)2019 Drug cost: $733,301 (USD; Tot_Drug_Cst)2020 Drug cost: $834,427 (USD; Tot_Drug_Cst)2021 Drug cost: $665,084 (USD; Tot_Drug_Cst)2022 Drug cost: $832,676 (USD; Tot_Drug_Cst)2023 Drug cost: $1,038,138 (USD; Tot_Drug_Cst)2024 Drug cost: $1,396,815 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20151,2533,639$387,634
20161,4894,378$400,117
20171,5774,104$780,494
20181,2693,052$605,345
20191,0192,557$733,301
20201,0192,799$834,427
20219712,748$665,084
20229303,019$832,676
20239313,199$1,038,138
20249523,181$1,396,815

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
17110Destruction of skin growth, 1-14 growths321389$72
11102Biopsy of related skin growth, first growth244281$60
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more7541,347$57
17000Destruction of precancer skin growth, 1 growth8111,383$35
17003Destruction of precancer skin growth, 2-14 growths7275,860$4

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Skyrizi PenRisankizumab-Rzaa241,960$519,393
Dupixent PenDupilumab952,618$374,024
Cosentyx Sensoready (2 Pens)Secukinumab15424$109,282
RinvoqUpadacitinib11330$69,328
KetoconazoleKetoconazole75022,756$14,737

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.174$22,986Dermavant Sciences, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Thomas W. Bender, MD?

Tedicare shows public-source Medicare data for Thomas W. Bender, MD (NPI 1649266792), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Thomas W. Bender, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Thomas W. Bender, MD?

Thomas W. Bender, MD is linked to FOREFRONT DERMATOLOGY, S.C. (billing NPI 1366936759) in the available physician profile data.

Does Thomas W. Bender, MD have Open Payments data?

Thomas W. Bender, MD has 174 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.